MedPath

Parecoxib

Generic Name
Parecoxib
Brand Names
Dynastat
Drug Type
Small Molecule
Chemical Formula
C19H18N2O4S
CAS Number
198470-84-7
Unique Ingredient Identifier
9TUW81Y3CE
Background

Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.

Indication

Used for short term perioperative pain control.

Associated Conditions
Postoperative pain

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

Phase 4
Completed
Conditions
Pain, Postoperative
Interventions
Drug: Normal saline injection
First Posted Date
2014-10-23
Last Posted Date
2015-08-28
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
74
Registration Number
NCT02272660
Locations
🇨🇳

The Peking Union Medical College Hospital, Beijing, Beijing, China

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

Phase 4
Conditions
Laparotomy Surgery
Hepatic Hemangioma Located in the Right Liver
Interventions
First Posted Date
2014-07-30
Last Posted Date
2014-07-30
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
100
Registration Number
NCT02204878
Locations
🇨🇳

Peking union medical college hospital, Beijing, Beijing, China

Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients

Phase 4
Completed
Conditions
Pain
Inflammation
Interventions
First Posted Date
2014-07-24
Last Posted Date
2019-04-19
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
246
Registration Number
NCT02198924
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty

Phase 2
Completed
Conditions
POSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFB
Interventions
Drug: CONTINUOUS FEMORAL BLOCK WITH ROPIVACAINE 0,2%
Drug: N/S 0.9%
First Posted Date
2014-07-10
Last Posted Date
2014-07-10
Lead Sponsor
Asklepieion Voulas General Hospital
Target Recruit Count
90
Registration Number
NCT02185924
Locations
🇬🇷

Department of Anaesthesia Asklepeion Voulas General Hospital, Voula Athens, Greece

Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery

Phase 4
Conditions
Gastrointestinal Cancer
Interventions
First Posted Date
2013-08-28
Last Posted Date
2014-11-10
Lead Sponsor
Jinling Hospital, China
Target Recruit Count
164
Registration Number
NCT01930318
Locations
🇨🇳

Jinling Hospital, Nanjing, Jiangsu, China

Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
First Posted Date
2013-05-22
Last Posted Date
2013-05-22
Lead Sponsor
Prince of Songkla University
Target Recruit Count
96
Registration Number
NCT01859585
Locations
🇹🇭

Faculty of Medicine, Prince of Songkla University, Hadyai, Sonkla, Thailand

Effect of Parecoxib on the Change of Shoulder Pain Threshold After Gynecological Laparoscopies

Phase 4
Completed
Conditions
Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies
Interventions
Drug: Placebo
First Posted Date
2013-04-30
Last Posted Date
2014-02-19
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
140
Registration Number
NCT01843010
Locations
🇨🇳

Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University., Guangzhou, Guangdong, China

Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery

Not Applicable
Completed
Conditions
Benign Female Reproductive System Neoplasm
Interventions
Drug: Normal saline
First Posted Date
2012-03-29
Last Posted Date
2012-09-24
Lead Sponsor
Liu Weifeng
Target Recruit Count
294
Registration Number
NCT01566669
Locations
🇨🇳

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy

Phase 4
Completed
Conditions
Pain, Postoperative
Interventions
First Posted Date
2012-02-06
Last Posted Date
2014-02-21
Lead Sponsor
G.Gennimatas General Hospital
Target Recruit Count
70
Registration Number
NCT01526525
Locations
🇬🇷

G.Gennimatas GENERAL HOSPITAL OF THESSALONIKI, Thessaloniki, Greece

Efficacy of Parecoxib on Patients With CRPS

Conditions
Causalgia
First Posted Date
2012-02-01
Last Posted Date
2012-04-25
Lead Sponsor
Ruhr University of Bochum
Registration Number
NCT01523379
© Copyright 2025. All Rights Reserved by MedPath